Insider Buying Sends Pulse Biosciences Stock Higher
Pulse Biosciences stock jumped after top executives bought $13M in shares, signaling strong confidence in future growth.
Already have an account? Sign in.
Pulse Biosciences stock jumped after top executives bought $13M in shares, signaling strong confidence in future growth.
The company expects to decide the best path by year-end 2026.
Stride shares plunged after Texas' Roscoe ISD decided not to renew its contract for Lone Star Online Academy, representing ~5% of 2025 enrollment. BMO highlights retention risks.
Context Therapeutics reported positive Phase 1 data for CTIM-76 in heavily pretreated platinum-resistant ovarian cancer, showing a 29% response rate and good safety, but the stock fell due to small trial size.